Hyperlipidemia
Hyperlipidemia refers to high blood lipid levels, which is a systemic disease caused by abnormal fat metabolism or operation, making plasma lipids higher than normal. It refers to high cholesterol or triglycerides in the blood, or low high-density lipoprotein cholesterol. Modern medicine calls it dyslipidemia. Hyperlipidemia can be divided into primary and secondary types. The former is related to the environment and family inheritance. The latter is caused by diabetes, hypothyroidism, obesity, pancreatitis, etc. It is particularly common in middle-aged and elderly people. According to statistics, the number of people with hyperlipidemia has reached 200 million. In addition, since there are no obvious symptoms in the early stage of hyperlipidemia, it is easy to be ignored by patients. It all happens unconsciously and can only be discovered during health examinations. Therefore, it is also called: the silent killer.
-
Site of disease:
Blood vessels -
Infectious :
Not contagious -
Frequent population:
Obese people -
Related symptoms:
Vascular sclerosis yellow nodules high blood pressure unstable angina diabetes -
Concurrent disease:
Related Drugs
Atorvastatin Calcium Tablets
Indication: 1. Hypercholesterolemia Patients with primary hypercholesterolemia, including familial hypercholesterolemia (heterozygous type) or mixed hyperlipidemia (equivalent to type IIa and IIb of Fredrickson classification), can use this product to treat elevated total cholesterol, elevated low-density lipoprotein cholesterol, elevated apolipoprotein B and elevated triglycerides if dietary therapy and other non-drug treatments are unsatisfactory. In patients with homozygous familial hypercholesterolemia, atorvastatin calcium can be used in combination with other lipid-lowering therapies (such as LDL plasma dialysis) or alone (when no other treatment is available) to lower total cholesterol and low-density lipoprotein cholesterol. 2. Coronary heart disease Coronary heart disease or coronary heart disease-related critical illnesses (such as diabetes, symptomatic atherosclerotic disease, etc.) combined with high
Manufacturer:
Beijing Jialin Pharmaceutical Co., Ltd.
Atorvastatin Calcium Tablets
Indication: Used to treat hypercholesterolemia and mixed hyperlipidemia; prevent and treat coronary heart disease and cerebral stroke.
Manufacturer:
Viatris Pharmaceuticals (DALIAN) Co., Ltd.
Fenofibrate Capsules
Indication: This product is used to treat hyperlipidemia in adults who have not responded well to dietary control therapy. Its effect on lowering triglycerides and mixed hyperlipidemia is more obvious than that of cholesterol. However, this product cannot completely replace dietary control therapy and can only be used as an auxiliary treatment based on dietary control.
Manufacturer:
Beijing Jingfeng Pharmaceutical Co., Ltd.
Fenofibrate Capsules
Indication: This product is used to treat hyperlipidemia (type IIa), endogenous hypertriglyceridemia, simple type (type IV) and mixed type (type IIb and III) in adults who are not well treated with dietary control therapy, especially when blood cholesterol continues to rise after dietary control, or there are other concurrent risk factors.
Gemfibrozil
Indication: Used for hyperlipidemia; suitable for patients with severe type IV or V hyperlipoproteinemia, high risk of coronary heart disease and those who have not responded to diet control, weight loss and other treatments; also suitable for patients with type IIb hyperlipoproteinemia, high risk of coronary heart disease and those who have not responded to diet control, weight loss and other blood lipid regulating drugs; in view of the potential carcinogenicity of this product to humans, its use should be strictly limited to the specified indications, and the drug should be discontinued promptly if the therapeutic effect is not obvious.
Gemfibrozil Capsules
Indication: Suitable for primary hyperlipidemia.
Manufacturer:
Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd.
Gemfibrozil Capsules
Indication: Suitable for primary hyperlipidemia.
Manufacturer:
Harbin Pharmaceutical Group Co., Ltd. GENERAL Pharm. FACTORY
Gemfibrozil Capsules
Indication: Suitable for primary hyperlipidemia.
Manufacturer:
Shanghai Zhonghua Pharmaceutical Co., Ltd.
Gemfibrozil Capsules
Indication: Suitable for primary hyperlipidemia.
Manufacturer:
Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd.
Pupa oil α-linolenic acid ethyl ester capsules
Indication: Used as an adjuvant treatment for hyperlipidemia and chronic hepatitis.
Manufacturer:
Beijing Baihui Biochemical Pharmaceutical Co., Ltd.
Related Ingredients